Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM) Abstract uri icon

authors

  • van den Bent, M
  • Lassman, AB
  • Gan, HK
  • Reardon, DA
  • Kumthekar, P
  • Butowski, N
  • Lwin, Z
  • Mikkelsen, T
  • Nabors, LB
  • Papadopoulos, KP
  • Penas-Prado, M
  • Simes, J
  • Wheeler, H
  • Gomez, E
  • Lee, H-J
  • Roberts-Rapp, L
  • Xiong, H
  • Bain, E
  • Holen, K
  • Merrell, R

publication date

  • December 1, 2016